Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Cancer Tissue Diagnostics Market Size Growth Rate by Type (2014-2025) 1.4.2 Immunohistochemistry (IHC) Test 1.4.3 In Situ Hybridisation Test 1.5 Market by Application 1.5.1 Global Cancer Tissue Diagnostics Market Share by Application (2019-2025) 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Cancer Tissue Diagnostics Market Size 2.2 Cancer Tissue Diagnostics Growth Trends by Regions 2.2.1 Cancer Tissue Diagnostics Market Size by Regions (2019-2025) 2.2.2 Cancer Tissue Diagnostics Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 3 Market Share by Key Players 3.1 Cancer Tissue Diagnostics Market Size by by Players 3.1.1 Global Cancer Tissue Diagnostics Revenue by by Players (2014-2019) 3.1.2 Global Cancer Tissue Diagnostics Revenue Market Share by by Players (2014-2019) 3.1.3 Global Cancer Tissue Diagnostics Market Concentration Ratio (CR5 and HHI) 3.2 Cancer Tissue Diagnostics Key Players Head office and Area Served 3.3 Key Players Cancer Tissue Diagnostics Product/Solution/Service 3.4 Date of Enter into Cancer Tissue Diagnostics Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Cancer Tissue Diagnostics Market Size by Type (2014-2019) 4.2 Global Cancer Tissue Diagnostics Market Size by Application (2014-2019) 5 North America 5.1 North America Cancer Tissue Diagnostics Market Size (2014-2019) 5.2 Cancer Tissue Diagnostics Key Players in North America 5.3 North America Cancer Tissue Diagnostics Market Size by Type 5.4 North America Cancer Tissue Diagnostics Market Size by Application 6 Europe 6.1 Europe Cancer Tissue Diagnostics Market Size (2014-2019) 6.2 Cancer Tissue Diagnostics Key Players in Europe 6.3 Europe Cancer Tissue Diagnostics Market Size by Type 6.4 Europe Cancer Tissue Diagnostics Market Size by Application 7 China 7.1 China Cancer Tissue Diagnostics Market Size (2014-2019) 7.2 Cancer Tissue Diagnostics Key Players in China 7.3 China Cancer Tissue Diagnostics Market Size by Type 7.4 China Cancer Tissue Diagnostics Market Size by Application 8 Japan 8.1 Japan Cancer Tissue Diagnostics Market Size (2014-2019) 8.2 Cancer Tissue Diagnostics Key Players in Japan 8.3 Japan Cancer Tissue Diagnostics Market Size by Type 8.4 Japan Cancer Tissue Diagnostics Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Cancer Tissue Diagnostics Market Size (2014-2019) 9.2 Cancer Tissue Diagnostics Key Players in Southeast Asia 9.3 Southeast Asia Cancer Tissue Diagnostics Market Size by Type 9.4 Southeast Asia Cancer Tissue Diagnostics Market Size by Application 10 India 10.1 India Cancer Tissue Diagnostics Market Size (2014-2019) 10.2 Cancer Tissue Diagnostics Key Players in India 10.3 India Cancer Tissue Diagnostics Market Size by Type 10.4 India Cancer Tissue Diagnostics Market Size by Application 11 Central & South America 11.1 Central & South America Cancer Tissue Diagnostics Market Size (2014-2019) 11.2 Cancer Tissue Diagnostics Key Players in Central & South America 11.3 Central & South America Cancer Tissue Diagnostics Market Size by Type 11.4 Central & South America Cancer Tissue Diagnostics Market Size by Application 12 International Players Profiles 12.1 F. Hoffmann-La Roche Ltd. 12.1.1 F. Hoffmann-La Roche Ltd. Company Details 12.1.2 Company Description and Business Overview 12.1.3 Cancer Tissue Diagnostics Introduction 12.1.4 F. Hoffmann-La Roche Ltd. Revenue in Cancer Tissue Diagnostics Business (2014-2019)) 12.1.5 F. Hoffmann-La Roche Ltd. Recent Development 12.2 Danaher Corporation 12.2.1 Danaher Corporation Company Details 12.2.2 Company Description and Business Overview 12.2.3 Cancer Tissue Diagnostics Introduction 12.2.4 Danaher Corporation Revenue in Cancer Tissue Diagnostics Business (2014-2019) 12.2.5 Danaher Corporation Recent Development 12.3 Thermo Fisher Scientific Inc. 12.3.1 Thermo Fisher Scientific Inc. Company Details 12.3.2 Company Description and Business Overview 12.3.3 Cancer Tissue Diagnostics Introduction 12.3.4 Thermo Fisher Scientific Inc. Revenue in Cancer Tissue Diagnostics Business (2014-2019) 12.3.5 Thermo Fisher Scientific Inc. Recent Development 12.4 Bio Rad Laboratories Inc. 12.4.1 Bio Rad Laboratories Inc. Company Details 12.4.2 Company Description and Business Overview 12.4.3 Cancer Tissue Diagnostics Introduction 12.4.4 Bio Rad Laboratories Inc. Revenue in Cancer Tissue Diagnostics Business (2014-2019) 12.4.5 Bio Rad Laboratories Inc. Recent Development 12.5 Abbott 12.5.1 Abbott Company Details 12.5.2 Company Description and Business Overview 12.5.3 Cancer Tissue Diagnostics Introduction 12.5.4 Abbott Revenue in Cancer Tissue Diagnostics Business (2014-2019) 12.5.5 Abbott Recent Development 12.6 Enzo Life Sciences, Inc. 12.6.1 Enzo Life Sciences, Inc. Company Details 12.6.2 Company Description and Business Overview 12.6.3 Cancer Tissue Diagnostics Introduction 12.6.4 Enzo Life Sciences, Inc. Revenue in Cancer Tissue Diagnostics Business (2014-2019) 12.6.5 Enzo Life Sciences, Inc. Recent Development 12.7 Agilent Technologies, Inc. 12.7.1 Agilent Technologies, Inc. Company Details 12.7.2 Company Description and Business Overview 12.7.3 Cancer Tissue Diagnostics Introduction 12.7.4 Agilent Technologies, Inc. Revenue in Cancer Tissue Diagnostics Business (2014-2019) 12.7.5 Agilent Technologies, Inc. Recent Development 12.8 Cancer Genetics Inc. 12.8.1 Cancer Genetics Inc. Company Details 12.8.2 Company Description and Business Overview 12.8.3 Cancer Tissue Diagnostics Introduction 12.8.4 Cancer Genetics Inc. Revenue in Cancer Tissue Diagnostics Business (2014-2019) 12.8.5 Cancer Genetics Inc. Recent Development 12.9 Merck KGaA (Sigma-Aldrich Co. LLC) 12.9.1 Merck KGaA (Sigma-Aldrich Co. LLC) Company Details 12.9.2 Company Description and Business Overview 12.9.3 Cancer Tissue Diagnostics Introduction 12.9.4 Merck KGaA (Sigma-Aldrich Co. LLC) Revenue in Cancer Tissue Diagnostics Business (2014-2019) 12.9.5 Merck KGaA (Sigma-Aldrich Co. LLC) Recent Development 12.10 Abcam plc. 12.10.1 Abcam plc. Company Details 12.10.2 Company Description and Business Overview 12.10.3 Cancer Tissue Diagnostics Introduction 12.10.4 Abcam plc. Revenue in Cancer Tissue Diagnostics Business (2014-2019) 12.10.5 Abcam plc. Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Product (2019-2025) 13.2 Market Size Forecast by Application (2019-2025) 13.3 Market Size Forecast by Regions 13.4 North America 13.5 Europe 13.6 China 13.7 Japan 13.8 Southeast Asia 13.9 India 13.10 Central & South America 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 15.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Cancer Tissue Diagnostics Key Market Segments Table Key Players Cancer Tissue Diagnostics Covered Table Global Cancer Tissue Diagnostics Market Size Growth Rate by Type 2018-2025 (Million US$) Figuer Immunohistochemistry (IHC) Test Figures Table Key Players of Immunohistochemistry (IHC) Test Figuer In Situ Hybridisation Test Figures Table Key Players of In Situ Hybridisation Test Table Global Cancer Tissue Diagnostics Market Size Growth by Application 2019-2025 (Million US$) Figure Global Cancer Tissue Diagnostics Market Share by Application in 2018 & 2025 Figure Hospitals Case Studies Figure Clinics Case Studies Figure Others Case Studies Figure Cancer Tissue Diagnostics Report Years Considered Figure Global Cancer Tissue Diagnostics Market Size and Growth Rate 2014-2025 (Million US$) Table Global Cancer Tissue Diagnostics Market Size by Regions 2019-2025 (Million US$) Table Global Cancer Tissue Diagnostics Market Size by Regions 2019-2025 (Million US$) Table Global Cancer Tissue Diagnostics Market Share by Regions 2014-2019 Figure Global Cancer Tissue Diagnostics Market Share by Regions 2014-2019 Figure Global Cancer Tissue Diagnostics Market Share by Regions in 2018 Table Market Top Trends Table Key Drivers: Impact Analysis (2019-2025) Table Key Challenges Figure PORTER'S FIVE FORCES ANALYSIS Table Global Cancer Tissue Diagnostics Revenue by by Players (2014-2019) (Million US$) Table Global Cancer Tissue Diagnostics Market Share by by Players (2014-2019) Figure Global Cancer Tissue Diagnostics Market Share by by Players in 2018 Table Global Cancer Tissue Diagnostics by Players Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Cancer Tissue Diagnostics Product/Solution/Service Table Date of Enter into Cancer Tissue Diagnostics Market Table Mergers & Acquisitions, Expansion Plans Table Global Cancer Tissue Diagnostics Market Size by Type (2014-2019) (Million US$) Table Global Cancer Tissue Diagnostics Market Size Share by Type (2014-2019) Figure Global Cancer Tissue Diagnostics Market Size Market Share by Type (2014-2019) Table Global Cancer Tissue Diagnostics Market Size by Application (2014-2019) (Million US$) Table Global Cancer Tissue Diagnostics Market Size Share by Application (2014-2019) Figure Global Cancer Tissue Diagnostics Market Size Market Share by Application (2014-2019) Figure Global Cancer Tissue Diagnostics Revenue Market Share by Application in 2018 Figure North America Cancer Tissue Diagnostics Market Size 2014-2019 (Million US$) Table North America Key Players Cancer Tissue Diagnostics Revenue (2018-2019) (Million US$) Table North America Key Players Cancer Tissue Diagnostics Market Share (2018-2019) Table North America Cancer Tissue Diagnostics Market Size by Type 2014-2019 (Million US$) Table North America Cancer Tissue Diagnostics Market Share by Type 2014-2019 Table North America Cancer Tissue Diagnostics Market Size by Application 2014-2019 (Million US$) Table North America Cancer Tissue Diagnostics Market Share by Application 2014-2019 Figure Europe Cancer Tissue Diagnostics Market Size 2014-2019 (Million US$) Table Europe Key Players Cancer Tissue Diagnostics Revenue (2018-2019) (Million US$) Table Europe Key Players Cancer Tissue Diagnostics Market Share (2018-2019) Table Europe Cancer Tissue Diagnostics Market Size by Type 2014-2019 (Million US$) Table Europe Cancer Tissue Diagnostics Market Share by Type 2014-2019 Table Europe Cancer Tissue Diagnostics Market Size by Application 2014-2019 (Million US$) Table Europe Cancer Tissue Diagnostics Market Share by Application 2014-2019 Figure China Cancer Tissue Diagnostics Market Size 2014-2019 (Million US$) Table China Key Players Cancer Tissue Diagnostics Revenue (2018-2019) (Million US$) Table China Key Players Cancer Tissue Diagnostics Market Share (2018-2019) Table China Cancer Tissue Diagnostics Market Size by Type 2014-2019 (Million US$) Table China Cancer Tissue Diagnostics Market Share by Type 2014-2019 Table China Cancer Tissue Diagnostics Market Size by Application 2014-2019 (Million US$) Table China Cancer Tissue Diagnostics Market Share by Application 2014-2019 Figure Japan Cancer Tissue Diagnostics Market Size 2014-2019 (Million US$) Table Japan Key Players Cancer Tissue Diagnostics Revenue (2018-2019) (Million US$) Table Japan Key Players Cancer Tissue Diagnostics Market Share (2018-2019) Table Japan Cancer Tissue Diagnostics Market Size by Type 2014-2019 (Million US$) Table Japan Cancer Tissue Diagnostics Market Share by Type 2014-2019 Table Japan Cancer Tissue Diagnostics Market Size by Application 2014-2019 (Million US$) Table Japan Cancer Tissue Diagnostics Market Share by Application 2014-2019 Figure Southeast Asia Cancer Tissue Diagnostics Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Cancer Tissue Diagnostics Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Cancer Tissue Diagnostics Market Share (2018-2019) Table Southeast Asia Cancer Tissue Diagnostics Market Size by Type 2014-2019 (Million US$) Table Southeast Asia Cancer Tissue Diagnostics Market Share by Type 2014-2019 Table Southeast Asia Cancer Tissue Diagnostics Market Size by Application 2014-2019 (Million US$) Table Southeast Asia Cancer Tissue Diagnostics Market Share by Application 2014-2019 Figure India Cancer Tissue Diagnostics Market Size 2014-2019 (Million US$) Table India Key Players Cancer Tissue Diagnostics Revenue (2018-2019) (Million US$) Table India Key Players Cancer Tissue Diagnostics Market Share (2018-2019) Table India Cancer Tissue Diagnostics Market Size by Type 2014-2019 (Million US$) Table India Cancer Tissue Diagnostics Market Share by Type 2014-2019 Table India Cancer Tissue Diagnostics Market Size by Application 2014-2019 (Million US$) Table India Cancer Tissue Diagnostics Market Share by Application 2014-2019 Figure Central & South America Cancer Tissue Diagnostics Market Size 2014-2019 (Million US$) Table Central & South America Key Players Cancer Tissue Diagnostics Revenue (2018-2019) (Million US$) Table Central & South America Key Players Cancer Tissue Diagnostics Market Share (2018-2019) Table Central & South America Cancer Tissue Diagnostics Market Size by Type 2014-2019 (Million US$) Table Central & South America Cancer Tissue Diagnostics Market Share by Type 2014-2019 Table Central & South America Cancer Tissue Diagnostics Market Size by Application 2014-2019 (Million US$) Table Central & South America Cancer Tissue Diagnostics Market Share by Application 2014-2019 Table F. Hoffmann-La Roche Ltd. Company Details Table F. Hoffmann-La Roche Ltd. Revenue in Cancer Tissue Diagnostics Business 2014-2019 (Million US$) Figure F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2014-2019) Table F. Hoffmann-La Roche Ltd. Recent Development Table Danaher Corporation Company Details Table Danaher Corporation Revenue in Cancer Tissue Diagnostics Business 2014-2019 (Million US$) Figure Danaher Corporation Revenue Growth Rate in Cancer Tissue Diagnostics Business (2014-2019) Table Danaher Corporation Recent Development Table Thermo Fisher Scientific Inc. Company Details Table Thermo Fisher Scientific Inc. Revenue in Cancer Tissue Diagnostics Business 2014-2019 (Million US$) Figure Thermo Fisher Scientific Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2014-2019) Table Thermo Fisher Scientific Inc. Recent Development Table Bio Rad Laboratories Inc. Company Details Table Bio Rad Laboratories Inc. Revenue in Cancer Tissue Diagnostics Business 2014-2019 (Million US$) Figure Bio Rad Laboratories Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2014-2019) Table Bio Rad Laboratories Inc. Recent Development Table Abbott Company Details Table Abbott Revenue in Cancer Tissue Diagnostics Business 2014-2019 (Million US$) Figure Abbott Revenue Growth Rate in Cancer Tissue Diagnostics Business (2014-2019) Table Abbott Recent Development Table Enzo Life Sciences, Inc. Company Details Table Enzo Life Sciences, Inc. Revenue in Cancer Tissue Diagnostics Business 2014-2019 (Million US$) Figure Enzo Life Sciences, Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2014-2019) Table Enzo Life Sciences, Inc. Recent Development Table Agilent Technologies, Inc. Company Details Table Agilent Technologies, Inc. Revenue in Cancer Tissue Diagnostics Business 2014-2019 (Million US$) Figure Agilent Technologies, Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2014-2019) Table Agilent Technologies, Inc. Recent Development Table Cancer Genetics Inc. Company Details Table Cancer Genetics Inc. Revenue in Cancer Tissue Diagnostics Business 2014-2019 (Million US$) Figure Cancer Genetics Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2014-2019) Table Cancer Genetics Inc. Recent Development Table Merck KGaA (Sigma-Aldrich Co. LLC) Company Details Table Merck KGaA (Sigma-Aldrich Co. LLC) Revenue in Cancer Tissue Diagnostics Business 2014-2019 (Million US$) Figure Merck KGaA (Sigma-Aldrich Co. LLC) Revenue Growth Rate in Cancer Tissue Diagnostics Business (2014-2019) Table Merck KGaA (Sigma-Aldrich Co. LLC) Recent Development Table Abcam plc. Company Details Table Abcam plc. Revenue in Cancer Tissue Diagnostics Business 2014-2019 (Million US$) Figure Abcam plc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2014-2019) Table Abcam plc. Recent Development Table Global Cancer Tissue Diagnostics Market Size by Regions (Million US$) 2019-2025 Figure Global Cancer Tissue Diagnostics Market Size Share by Regions (2019-2025) Figure Global Cancer Tissue Diagnostics Market Size Share by Regions in 2025 Figure North America Cancer Tissue Diagnostics Market Size Forecast (2019-2025)(Million USD) Figure Europe Cancer Tissue Diagnostics Market Size Forecast (2019-2025)(Million USD) Figure China Cancer Tissue Diagnostics Market Size Forecast (2019-2025)(Million USD) Figure Japan Cancer Tissue Diagnostics Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Cancer Tissue Diagnostics Market Size Forecast (2019-2025)(Million USD) Figure India Cancer Tissue Diagnostics Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Cancer Tissue Diagnostics Market Size Forecast (2019-2025)(Million USD) Table Global Cancer Tissue Diagnostics Market Size by Product (2019-2025) (Million US$) Figure Global Cancer Tissue Diagnostics Market Size by Product (2019-2025) Figure Global Cancer Tissue Diagnostics Market Size by Product in 2025 Table Global Cancer Tissue Diagnostics Market Size by Application (2019-2025) (Million US$) Figure Global Cancer Tissue Diagnostics Market Size by Application (2019-2025) Figure Global Cancer Tissue Diagnostics Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

F. Hoffmann-La Roche Ltd. Danaher Corporation Thermo Fisher Scientific Inc. Bio Rad Laboratories Inc. Abbott Enzo Life Sciences, Inc. Agilent Technologies, Inc. Cancer Genetics Inc. Merck KGaA (Sigma-Aldrich Co. LLC) Abcam plc.